| NDC Code | 50419-385-01 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (50419-385-01) / 4 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 50419-385 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Aliqopa |
|---|
| Non-Proprietary Name | Copanlisib |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20170914 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA209936 |
|---|
| Manufacturer | Bayer HealthCare Pharmaceuticals Inc. |
|---|
| Substance Name | COPANLISIB |
|---|
| Strength | 15 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Kinase Inhibitor [EPC], Kinase Inhibitors [MoA] |
|---|